June 29, 2023 (Earnings Report) Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Constellation Brands
Symbol: STZ
Recent Price: $246.78
Average Analyst Price Target: $265.22 (9.53%)
Market Cap: $45.26B
Last Year's EPS: 2.83
Consensus EPS Forecast: 1.82
Expected Earnings Date: 2023-04-06
Recent Analyst Action: Gerald Pascarelli, analyst at Wedbush, reiterates coverage on Constellation Brands (STZ) in the Consumer Defensive sector with a Buy rating and a price target of $270 (1 day ago).
TipRanks.com also reports that Constellation Brands currently has 20 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $265.22 . The target pricing ranges from a high forecast of $305.00 down to a low forecast of $200.00. Constellation Brands (STZ)’s last closing price was $246.78 which would put the average price target at 9.53% upside.Here are 3rd party ratings for STZ:
Recent Analyst Action: Christoph Gretler, analyst at Credit Suisse, reiterates coverage on Gerresheimer (GRRMF) in the Industrials sector with a Buy rating and a price target of $120.41 (16 hours ago).
TipRanks.com also reports that Gerresheimer currently has analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is . The target pricing ranges from a high forecast of down to a low forecast of . Gerresheimer (GRRMF)’s last closing price was $96.30 which would put the average price target at 36.71% upside.Here are 3rd party ratings for GRRMF:
Recent Analyst Action: Joseph Schwartz, analyst at SVB Securities, reiterates coverage on KalVista Pharmaceuticals (KALV) in the Healthcare sector with a Buy rating and a price target of $20 (1 month ago).
TipRanks.com also reports that KalVista Pharmaceuticals currently has 15 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $38.00 . The target pricing ranges from a high forecast of $38.00 down to a low forecast of $38.00. KalVista Pharmaceuticals (KALV)’s last closing price was $9.16 which would put the average price target at 129.26% upside.Here are 3rd party ratings for KALV:
Recent Analyst Action: Jon Tower, analyst at Citi, reiterates coverage on Kura Sushi USA (KRUS) in the Consumer Cyclical sector with a Hold rating and a price target of $88 (3 weeks ago).
TipRanks.com also reports that Kura Sushi USA currently has 14 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $53.00 . The target pricing ranges from a high forecast of $53.00 down to a low forecast of $53.00. Kura Sushi USA (KRUS)’s last closing price was $90.66 which would put the average price target at -12.03% upside.Here are 3rd party ratings for KRUS:
Recent Analyst Action: Drew Crum, analyst at Stifel Nicolaus, reiterates coverage on Levi Strauss & Co (LEVI) in the Consumer Cyclical sector with a Buy rating and a price target of $19 (2 months ago).
TipRanks.com also reports that Levi Strauss & Co currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $23.67 . The target pricing ranges from a high forecast of $36.00 down to a low forecast of $17.00. Levi Strauss & Co (LEVI)’s last closing price was $14.34 which would put the average price target at 26.43% upside.Here are 3rd party ratings for LEVI:
Recent Analyst Action: Matt Hewitt, analyst at Craig-Hallum, reiterates coverage on Simulations Plus (SLP) in the Healthcare sector with a Buy rating and a price target of n/a (1 week ago).
TipRanks.com also reports that Simulations Plus currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $67.00 . The target pricing ranges from a high forecast of $67.00 down to a low forecast of $67.00. Simulations Plus (SLP)’s last closing price was $43.22 which would put the average price target at 48.08% upside.Here are 3rd party ratings for SLP:
To Your Financial Future,
The Editor, WallStreetSectors.com